Characterization of Potential New Targets and Therapeutic Agents for Nasopharyngeal Carcinoma
博士 === 國立陽明大學 === 臨床醫學研究所 === 107 === Cisplatin-based chemoradiotherapy is the mainstay treatment for advanced nasopharyngeal carcinoma (NPC). Patients with advanced NPC may suffer from severe treatment-related side effects, and a substantial number of patients may have tumor recurrence or distant m...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | en_US |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/m24x62 |